---
DrugClass: "[[Antihyperlipidemic Drugs]]"
SubClass: 
DrugClassContra: "[[Antihyperlipidemic Drugs#Contraindications]]"
DrugClassAdverse: "[[Antihyperlipidemic Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
ThirdDrugClass: 
ThirdSubClass: 
BrandName: Niaspan, Niacor
Chapter: "33"
KindleLinkChap: "[Chapter 33](kindle://book?action=open&asin=B09FRF11YJ&location=17954)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases:
---
```smiles
C1=CC(=CN=C1)C(=O)O
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Adjunctive treatment for [[hyperlipidemia]]
Immediate release: 1– 2 g orally BID, TID 
Extended release: 500– 2000 mg/ day orally

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Generalized flushing, sensation of warmth, severe itching and tingling, nausea, vomiting, abdominal pain

### Interactions

`= this.ChemLink+this.file.name`

